Novartis AG (NVS) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
RichardSanchez RichardSanchez 01/09/2016 3 months $81.56 $74.91 -8.15% -8 Ended
laurvp laurvp 11/03/2015 3 months $90.21 $77.92 -13.62% 13 Ended
Asclepius Asclepius 05/03/2015 3 months $103.35 $103.79 +0.43% 1 Ended
Comments: Great company with lots of good drugs.
pwahrn pwahrn 01/17/2015 3 months $100.95 $103.29 +2.32% 2 Ended
Comments: Industry sector growing
Jash Sayani Jash Sayani 07/13/2014 3 months $89.52 $87.71 -2.02% -2 Ended
Shabbir P Shabbir P 04/02/2013 1 Year $71.32 $84.52 +18.51% 18 Ended
Comments: Losing patent cases will increase focus on new drug development
WSBNN WSBNN 07/23/2012 1 Year $57.09 $54.75 -4.1% -4 Ended
Comments: Sandoz completes acquisition of Fougera Pharmaceuticals ... Read the full entry
Frippe Frippe 09/26/2011 3 months $53.73 $57.36 +6.76% 6 Ended
Comments: Upcoming product launch will be successful
bernad bernad 07/16/2011 3 months $61.54 $57.36 -6.79% -6 Ended
Comments: Industry sector growing or poised for growth
Teko Teko 11/23/2009 3 months N/A Ended
PI262 PI262 11/04/2009 3 months N/A Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.